Strüngmann Brothers invest in eHealth Specialist ICW

InterComponentWare AG (ICW)Santo Holding (Germany) GmbH of Hexal founders Strüngmann secured a 25 percent share in the eHealth specialist InterComponentWare AG (ICW). This transaction was performed by the purchase of newly issued shares in the context of an increase in capital stock. The present owners of ICW do not surrender any shares in this transaction.

ICW will invest its newly acquired funds into the further expansion of its leading position in the international eHealth market. The company is one of the internationally active eHealth pioneers and offers a very broad range of solutions focusing on citizens respectively patients.

ICW pursues two strategic approaches to improve communication and thus also quality and efficiency in the health care system: First of all, it supports the introduction of ubiquitous secure health care IT infrastructures with electronic health cards and personal health records. At the beginning of 2007, ICW was awarded the pilot project for the introduction of the national electronic health card in Bulgaria. The company also conducts a field test for the electronic health card in Germany since 2005, which includes the personal health record LifeSensor. The LifeSensor technology is also applied in the BARMER research project, in which Germany's largest health insurance company will offer its approx. 7 million insurants a personal health record.

ICW's second strategic approach is to network medical professionals in medical practices and hospitals with each other. PPV, for example, a Bavarian physician's network, uses ICW solutions to give its approximately 350 members a comprehensive view of their patients' medical data. Heidelberg University Hospital also opted for a solution developed by ICW to network with its partner hospitals. This solution also incorporates patients and resident physicians into the improved data flow.

"The trust of our new investors in ICW shows that we are pursuing the right strategy and that our solutions have a large national and international market potential", explains ICW's CEO Peter Reuschel. The Strüngmann brothers are also absolutely convinced that ICW will continue to expand its position in the global eHealth market: "We opted for an investment in ICW, because it is in a perfect position to assert itself in the high-growth global eHealth market with its open platform approach and mature solutions. With its networking solutions, ICW has the potential to make the national and global health care market more efficient. We want to support and accompany this process", explain the Strüngmann brothers.

Related news articles:

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for the healthcare IT infrastructure for electronic health cards, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has won the pilot project for the national health card in Bulgaria. For further information, visit:

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...